Heart Failure Optimization Study

CompletedOBSERVATIONAL
Enrollment

602

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

June 1, 2022

Study Completion Date

June 1, 2022

Conditions
Sudden Cardiac DeathSudden Cardiac ArrestHeart FailureHeart Failure Low Output
Interventions
DEVICE

Wearable Cardioverter Defibrillator

LifeVest is the brand of Wearable Cardioverter Defibrillator used in this study.

Trial Locations (67)

4020

Ordensklinikum Linz GmbH/Elisabethinen, Linz

13088

SJH Cardiology, Liverpool

14215

Trinity Medical Center, Buffalo

18840

Guthrie Medical Group, P.C., Sayre

19102

Drexel University, Philadelphia

19140

Temple University Hospital, Philadelphia

22043

Asklepios Klinik Wandsbek, Hamburg

22291

Asklepios Klinik Barmbek, Barmbek

25702

St. Mary's Medical Center, Huntington

26554

Beacon Medical Group clinical Research, South Bend

27599

UNC Chapel Hill, Chapel Hill

29720

Carolina Heart Specialists, Lancaster

30625

Medizinische Hochschule Hannover, Hannover

31076

Clinique Pasteur, Toulouse

32034

Baptist Heart Specialists, Fernandina Beach

32207

Baptist Heart Specialists, Jacksonville

32250

Baptist Heart Specialists, Jacksonville Beach

32825

Research Physicians Network Alliance, Orlando

33709

Study Site, St. Petersburg

34471

Institute of Cardiovascular Research, Ocala

35033

CHU Pontchaillou, Rennes

35294

UAB Division of Cardiovascular Disease, Birmingham

35392

UKGM, Standort Giessen, Giessen

37830

Parkway Cardiology, Oak Ridge

38043

CHU de Grenoble site Nord- Hopital Albert Michallon, Grenoble

38104

Methodist University Hospital (MUH) and Methodist OliveBranch (MOB), Memphis

38116

Methodist South (MS) University Hospital, Memphis

38642

Asklepios Harzklinik Goslar, Goslar

39216

Jackson Heart Clinic, Jackson

40225

Universitaetsklinikum Duesseldorf, Düsseldorf

40741

Saint Joseph London, London

44203

City Cardiology Associates, Barberton

44534

Katholisches Klinikum Lunen, Lünen

45138

Elisabeth-Krankenhaus, Essen

46321

Cardiovascular Research of Northwest Indiana, LLC, Munster

48602

Covenant Medical Center, Inc., Saginaw

50733

St. Vinzenz Hospital, Cologne

57104

Sanford Health, Sioux Falls

58515

Klinikum Ludenscheid, Lüdenscheid

60429

Chicago Medical Research, LLC, Hazel Crest

60506

Fox Valley Clinical Research Center, Aurora

61602

Unity Point Health-Methodist, Peoria

63003

CHU de Clermont-Ferrand- Hopital Albert Michallon, Grenoble

63136

St. Louis Heart and Vascular, St Louis

63367

SSM Health Heart & Vascular, Lake Saint Louis

64111

Saint Luke's Hospital of Kansas City, Kansas City

75015

Hopital Europeen Georges Pompidou, Paris

75231

Texas Health Research & Education Institute, Dallas

76712

Providence Health Center, Waco

78052

Schwarzwald-Baar Klinik, Villingen-Schwenningen

78130

Mission Research Insitute, New Braunfels

85221

Amper Kliniken AG, Heliios Amper-Klinikum Dachau, Dachau

86156

Klinikum Augsburg, Augsburg

91106

Centre Hospitalier Sud Francilien, Corbeil-Essonnes

91307

Study Site, West Hills

93042

Klinik u. Polikllinik Fur Innere Med. II Kardiologie, Regensburg

97616

Herz- und Gefäßklinik Bad Neustadt, Bad Neustadt an der Saale

02114

Massachusetts General Hospital, Boston

07601

Hackensack Meridian Health, Hackensack

08240

AtlantiCare Regional Medical Center, Pomona

08043

Lourdes Cardiology Services, Voorhees Township

Unknown

Medizinische Universitätsklinik Wien, Vienna

Charité Universitätsmedizin Berlin, Berlin

Kardiologie, Asklepios Klinik St. Georg, Hamburg

Universitätsklinikum Ulm, Ulm

06120

Universitatsklinikum Halle, Halle

04289

Herzzentrum Leipzig GmbH, Leipzig

All Listed Sponsors
lead

Zoll Medical Corporation

INDUSTRY

NCT03016754 - Heart Failure Optimization Study | Biotech Hunter | Biotech Hunter